It’s not known whether Cosentyx (secukinumab) is safe to receive while pregnant or breastfeeding. Certain factors may ...

Novartis’ psoriasis drug, Cosentyx (secukinumab) received a boost after data showed it is better at clearing skin than Johnson & Johnson’s rival Stelara. Cosentyx is one of several newer drugs ...

Cosentyx has already achieved blockbuster status but is behind Johnson & Johnson’s established psoriasis Stelara (ustekinumab) in terms of sales, with the latter generating more than $4 billion ...

Medically reviewed by Susan Bard, MD Rosacea, psoriasis, and eczema share some symptoms, such as rashes, bumps, redness, and itching. However, they are different conditions, though it is possible to ...

Psoriasis was less likely to progress to psoriatic ... IL-17 inhibitors included secukinumab (Cosentyx), ixekizumab (Taltz), and brodalumab (Siliq). In the IL-23 inhibitor class were guselkumab ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

Cosentyx (secukinumab) may be safe to use while pregnant or breastfeeding. Before starting treatment, you and your doctor can discuss the risks and benefits of Cosentyx treatment during pregnancy ...

Generalized pustular psoriasis (GPP) is considered a rare ... Other types of biologics, such as ixekizumab (Taltz) or secukinumab (Cosentyx), may be used when initial treatment with spesolimab ...